Large scale genome sequencing and integrative analyses to define genomic predictors of recurrent pregnancy loss
Primary Objective
Our work will generate new hypotheses regarding the genetic etiology of RPL and other related conditions, which may ultimately lead to the development of a clinical diagnostic test for families with RPL and improve our ability to counsel and help millions of couples with RPL.
Description
Aim 1: We will collect samples from of clinically well-characterized trios (products of conception (POC), biological mother, and biological father) with a history of unexplained RPL. Specially, we will recruit a cohort of 1,000 RPL trios that are rigorously-phenotyped and not attributable to known causes of RPL. For each RPL trio, POC tissues and parental blood samples (from both biological parents) will be collected. We will consider establishing cell lines from POC if technically feasible. If it is necessary for the purpose of determining the pathogenicity of genomic variants detected via whole genome sequencing (WGS), we will consider collecting blood samples from other family members after obtaining consent. The study team may also request DNA or POC tissues from prior pregnancy losses if available. Aim 2: We will perform WGS at the Yale Center for Genome Analysis (YCGA) and other bioinformatic analyses to identify pathogenic variants in RPL trios. We will comprehensively define pathogenic variants and generate fully annotated variant maps for all RPL trios to provide the substrate for subsequent novel gene discovery, and ultimately, for the development of clinical diagnostic tests.
Details
Locations
Outpatient CTRC
SGF Colorado - Colorado Springs
SGF Colorado - Denver
Principal Investigator
Nanette Santoro
Study ID
Protocol Number: 21-3533
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers